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Brief CommunicationThe reward value of sucrose in leptin-deficient
obese miceAna I. Domingos 1,*, Jake Vaynshteyn 3, Aylesse Sordillo 1, Jeffrey M. Friedman 1,2,**ABSTRACTLeptin-deﬁcient patients report higher “liking” ratings for food, and leptin replacement therapy normalizes these ratings even before weight loss is
achieved. Since animals cannot report their ratings, we studied the relationship between leptin and food reward in leptin-deﬁcient ob/ob mice using
a optogenetic assay that quantiﬁes the reward value of sucrose. In this assay, mice chose between one sipper dispensing the artiﬁcial sweetener
sucralose coupled to optogenetic activation of dopaminergic (DA) neurons, and another sipper dispensing sucrose. We found that the reward value of
sucrose was high under a state of leptin deﬁciency, as well as at a dose of leptin that does not suppress food intake (12.5 ng/h). Treatment with
higher doses of leptin decreased the reward value of sucrose before weight loss was achieved (100 ng/h), as seen in leptin-deﬁcient patients. These
results phenocopy in mice the behavior of leptin-deﬁcient patients.
& 2013 The Authors. Published by Elsevier GmbH.
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Leptin is an adipose tissue hormone that functions as an afferent signal
in a negative feedback loop that maintains relative constancy of adipose
tissue mass [3]. Leptin functions as a homeostatic signal to control food
intake, and recent studies have shown that leptin reduces food intake in
part by diminishing the reward value of sucrose [1,2]. In humans, the
reward value of food is assessed using a subjective rating scale for
“liking”. Leptin-deﬁcient patients report higher “liking” ratings for food,
and leptin replacement therapy normalizes these ratings even before
weight loss is achieved [1]. Assays of “liking” in rodents are limited by
the fact that animals cannot verbally report their ratings. In order to
assay “liking” in mice, we recently developed a two-bottle choice assay
that measures preference for sucrose versus a reference stimulus in
which ingestion of sucralose induces optogenetic stimulation of
dopaminergic (DA) neurons [2,4,5]. In this assay, changes in preference
relative to this optogenetic reference stimulus reﬂect changes in the
reward value of the nutrient in the second bottle, in this case sucrose
[2]. Using this assay, we previously accessed in wild-type mice the
reward value of sucrose under different metabolic states – food
restriction leading to weight loss increases the reward value of sucrose,
and this increase is reversed by leptin. However, these results involved
weight loss, and hence do not dissociate the hormonal effect from
an effect of the body mass. In this report, we studied the effects of
leptin treatment of ob mice on the reward value of sucrose beforehttp://dx.doi.org/10.1016/j.molmet.2013.10.007
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of leptin-deﬁcient humans, in which leptin treatment normalized the
reward value of food even before weight loss.2. MATERIALS AND METHODS
2.1. Animals
Dat-cre transgenic mice were obtained from the Laboratory of Nils-
Goran Larsson, Karolinska Institutet [6]. Heterozygous ob/þ mice were
obtained from Jackson Laboratories. Animals of either sex were kept in
C57BL/7 background. Unless speciﬁed otherwise, mice were single
housed and maintained under an inverted 12-h light/dark cycle, so that
behavioral tests could be performed during the rodent active phase
(dark). Standard chow and water were provided ad libitum, except
during acclimatization to the behavioral chambers and laser training (see
Section 2.3). Experimental protocols were approved by The Rockefeller
University IACUCs and met the guidelines of the national Institutes of
Health guide for the Care and Use of Laboratory Animals.
2.2. Virus preparation
To construct Cre-inducible recombinant AAV vectors, the DNA cassette
carrying two pairs of incompatible lox sites (loxP and lox2722) was
synthesized and the ChR2-mCherry transgene was inserted between the
loxP and lox2722 sites in the reverse orientation [4]. The resulting2Howard Hughes Medical Institute, Rockefeller University, 1230 York Avenue, New York, NY 10065,
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Brief Communicationdouble ﬂoxed reverse ChR2-mCherry cassette was cloned into a
modiﬁed version of the pAAV2-MCS vector carrying the EF-1α promoter
and the Woodchuck hepatitis virus posttranscriptional regulatory element
(WPRE) to enhance expression [4]. The recombinant AAV vectors were
serotyped with AAV5 coat proteins and packaged by the viral vector core
facility at the University of North Carolina. The ﬁnal viral concentration
was 2 1012 genome copies/mL [4].
2.3. Surgeries
Surgical procedures were adapted from [2]. Virus or vehicle was
injected via a pressure injector through pulled glass pipettes, which
were positioned to the ventral tegmental area (VTA) on coordinates
AP¼3.5 mm ML¼70.5 mm, DV¼4.8 mm (Paxinos) with a stereo-
taxic frame. The ﬁber optic ferrule (Thorlabs) was chronically implanted
with a stereotaxic frame, being secured with dental cement (Lang), and
aimed at the aforementioned coordinates. Animals were allowed to
recover from surgery for one week prior to any behavioral assays.
2.4. Behavioral and optogenetic setup
The lick-induced optogenetic stimulation has been described in our
previous publication [2]. Brieﬂy, MedAssociates chambers were
equipped with two contact lickometers and a laser source (solid state
Crystal laser, 473-nm wavelength) controlled by MedPC via a TTL
impulse to be triggered upon lick detection. The laser turns on every ﬁve
consecutive licks on the same sipper, being ON for one second and OFF
for the following second. Animals were water deprived for 16–23 h, and
acclimated to the chambers until side preference for either sipper was
even, which required about one week. During the acclimation period
mice were water deprived and were given water through the sippers
inside the chamber for half an hour. Two-bottle preference was
calculated as the ratio: preference for sipper1¼number of licks on
sipper1/(number of licks on sipper1þnumber of licks on sipper2) and
expressed as percentage values, with 50% representing the indifference
ratio. Behavioral data were analyzed with Excel, and expressed asVTA
Chr2
mCherry
Figure 1: Tissue-specific expression of channelrhodopsin in DA neurons of ob/ob mice and crania
led to ChR2-mCherry expression in neurons colocalizing with tyrosine hydroxylase (TH), a marker fo
were implanted above the VTA (red inset box in (d)) of ob/ob;Dat-cre mice.
74 MOLECULAR METABOLISM 3 (2014) 73–80 & 2013 The Aumean7SEM. Signiﬁcance tests comparing groups were t-tests, and,
when appropriate, followed by Bonferroni corrections for multiple
comparisons. After recovering from surgery animals were given water
inside the chamber for half an hour, for four consecutive days. During
day 1 mice were given water through one of the sippers, with the laser
source being triggered upon licking as mentioned above (Laser
Sipper¼LS). Laser/sipper coupling was balanced. On day 2 mice were
given water only through the other sipper, in the absence of laser
activation (Control Sipper¼CS). Day 3 and day 4 were, respectively,
repetitions of days 1 and day 2. On the ﬁfth day animals were given LS
and CS simultaneously for 10 min. Once a clear bias towards LS was
established (above 55%), animals were subjected to experiments testing
the effects of different doses of leptin on the reward value of sucrose
(Figures 3–5). Concentrations of sucrose and sucralose were set as
published elsewhere and were, respectively, 140 mM and 0.5 mM [2].
2.5. Immunohistochemistry
Immunohistochemistry was performed following the protocols as
published elsewhere [2], using a rabbit anti-TH (Pel-Freez, 1:1000)
antibody and appropriate host secondary antibodies.
2.6. Leptin treatment
Recombinant mouse leptin was obtained from Amylin Pharmaceuticals (San
Diego, CA) and administered through subcutaneous osmotic pumps (Alzet;
Palo Alto, CA) ﬁlled with the indicated concentrations of leptin and incubated
overnight at 37 1C in sterile 0.9% NaCl, and implanted subcutaneously in
10- to 14-week-old mice. Posology is described in Figure 2.3. RESULTS
3.1. Optogenetic targeting of dopaminergic neurons in ob/ob mice
We directed the expression of Channelrhodopsin-2 (ChR2) to DA neurons of
the midbrain of genetically obese ob/ob mice as follows (Figure 1): Dat-creLaser
Fiber optic
Cement
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l fiber optic implant. (a–c) AAV-DIO–ChR2-mCherry injection into the VTA of ob/ob;Dat-cre mice
r DA neurons (statistics imbedded in text, scale bars represent 100 mm). (d and e) Optical fibers
thors. Published by Elsevier GmbH. www.molecularmetabolism.comOpen access under CC BY-NC-ND license.
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Figure 2: Leptin withdrawal protocol in implanted ob/ob Dat-cre mice. (a) This experimental
design, in which the low dose was given before cranial surgery, was intended to improve implant
stability, postoperative recovery and survival of ob/ob Dat-cre mice, minimizing the number of
animals to be genotyped, implanted and euthanized. Mice had 14 days of leptin treatment
before and after surgery and were behaviorally assayed before changing osmotic pumps.
(b) Serum leptin levels were consistent with the dose regimen. Only the threshold dose induced
serum leptin levels that were different from background serum leptin levels of untreated ob/ob
mice (statistics imbedded in text). Bars are mean7SEM, ****po0.000022.mice were bred to heterozygous ob/þ mice, to generate ob/ob;Dat-cre
mice. We stereotaxically injected a Cre-inducible adeno-associated virus
carrying the gene encoding ChR2 fused to mCherry (AAV-DIO–ChR2-
mCherry) into the ventral tegmental area (VTA) of ob/ob mice (Figure 1d).
The nonrecombined construct is in the antisense orientation and is not
expressed. Cre-mediated recombination activates ChR2-mCherry
expression. The speciﬁcity of ChR2-expression in DA neurons was
conﬁrmed using immunohistochemistry, which revealed colocalization of
mCherry and tyrosine hydroxylase (TH) (Figure 1a–c). Transduction
efﬁciency averaged 7578% (n¼8) of TH-positive neurons, a value that
is similar to that we have previously seen in viral transduction of wild
type animals [2]. We next implanted an optical ﬁber into the VTA region
of ob/ob;Dat-cre;AAV-DIo–ChR2-mCherry mice (Figure 1e) [2].
3.2. Leptin treatment and withdrawal of implanted ob/ob Dat-cre mice
In initial experiments we encountered signiﬁcant postoperative compli-
cations among ob animals that were not treated with leptin. Speciﬁcally,
we noted that after implantation of the optical ﬁber, there was often
excessive bleeding at the craniotomy site, which compromised the
stability of the implant, and had a negative effect on postoperative
recovery. This limited our ability to assay the preference of naïve ob
mice. Therefore, we employed a leptin withdrawal protocol in which
animals were ﬁrst treated with a low dose of leptin (12.5 ng/h) before
and after implantation of the optical ﬁber. Consistent with prior reports
of the effect of leptin on immune and hematopoietic functions [7,8]
leptin treatment dramatically reduced the frequency of post-operative
complications in ob mice. After behavioral assays of animals treated
with this dose of leptin, the osmotic pumps were removed and new
pumps delivering a higher dose of leptin were implanted (100 ng/h),
after which the animals were restudied at this higher dose. Finally, to
study the behavior of animals in the absence of circulating leptin, the
leptin osmotic pumps were removed after the assays of leptin treatment
at the 100 ng/h dose were completed. Since the t1/2 of leptin in rodents
is 30 min, leptin levels decay to 0 within a day, and animals were
studied 48 h post-leptin withdrawal. The use of this leptin withdrawal
protocol allowed us to circumvent the aforementioned postoperative
complications and perform behavioral assays in mice in the absence of
circulating leptin.
In this leptin treatment/withdrawal protocol, animals are studied at three
time points as indicated in Figure 2a. As described above, in this
protocol, mice are ﬁrst treated 14 days prior to surgery, and also 14
days postoperatively, with a dose of leptin (12.5 ng/h) which resulted in
a leptin level of 0.9170.12 ng/mL (Figure 2b). Throughout the text we
refer to the 12.5 ng/h dose as a subthreshold dose. It is well established
that leptin treatment with a higher dose (100 ng/h) has an acute effect
on food intake [3]. We refer to this 100 ng/h dose as a threshold dose
which led to a leptin level of 3.870.49 ng/mL (Figure 2b). The leptin
level after withdrawal of the osmotic pumps was 0.2470.09 ng/mL,
which is not statistically different from background serum leptin levels of
untreated ob/ob mice (Figure 2b) (p40.18, t-test with Bonferroni
correction for multiple comparisons). Indeed, only the threshold dose
signiﬁcantly increased serum leptin levels above background levels
(****po0.000022, t-test with Bonferroni correction for multiple
comparisons).
One week prior to implantation of the optical ﬁber, control ob/ob;Chr2
mice and ob/ob;Chr2þ mice received the subthreshold dose of leptin
subcutaneously. This dose of leptin had no effect on body weight and
food intake (Figure 3a and b) even after 28 days of treatment (ChR2 :
p40.2, ChR2þ :p40.17). Note, while the subthreshold dose of leptin
did not alter food intake, it has been previously shown to be effective inMOLECULAR METABOLISM 3 (2014) 73–80 & 2013 The Authors. Published by Elsevier GmbH. Open acorrecting plasma glucose, which may also contribute to the diminished
bleeding during the surgical procedure in animals treated with this or
higher doses of leptin [9].
3.3. The reward value of sucrose in ob/ob mice treated with a
subthreshold dose of leptin
We analyzed an animals' preference for (i) water versus optogenetic
activation of DA neurons (Figure 3c) and (ii) sucrose versus sucralose
plus optogenetic activation of DA neurons (Figure 3d), in ob mice treated
with the subthreshold dose of leptin. ob/ob;Chr2þ mice (n¼8)
preferred water coupled to laser activation of DA neurons to water
alone, displaying 8375% preference for the sipper that was coupled to
laser activation. This preference ratio was signiﬁcantly different from the
preference ratio of control ob/ob;Chr2 mice (n¼8), that showed a
4877% (iso)preference for the laser side (**po0.0014, two-sample
t-test) (Figure 3c).
We next measured the reward value of sucrose in ob/ob;Dat-cre mice
treated with the subthreshold dose (12.5 ng/h) (Figure 3d). Both ob/ob;
Chr2 and ob/ob;Chr2þ animals preferred sucrose to sucralose
coupled to laser activation with preference ratios of, 8377% (n¼8)
and 8275% respectively (n¼8) (p40.47 two-sample t-test)75www.molecularmetabolism.comccess under CC BY-NC-ND license.
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Figure 3: Subthreshold leptin treatment did not suppress the reward value of sucrose in ob/ob
mice. (a) A subthreshold dose had no significant effect either on both eating behavior or on
(b) body weight (statistics imbedded in text). (c) ob/ob;Chr2þ , but not ob/ob;Chr2 mice,
were sensitive to the rewarding effect of optogenetic activation of DA neurons during a regimen
of leptin treatment of 12.5 ng per gram of body weight. ob/ob;Chr2þ , but not ob/ob;Chr2
mice, preferred to lick the sipper coupled to laser stimulation of DA neurons. (d) Both ob/ob;
Chr2þ and control ob/ob;Chr2 mice preferred sucrose to sucralose coupled to laser
stimulation of DA neurons (statistics imbedded in text). Bars are mean7SEM, **po0.0014.
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Brief Communication(Figure 3d). Thus a low dose of leptin that does not alter food intake has
no effect on the animals' preference for sucrose suggesting that this
leptin dose is insufﬁcient to alter the reward value of sucrose (Figure 3a
and d).Figure 4: Threshold leptin treatment decreased the reward value of sucrose in ob/ob mice
before weight loss. (a and b) A threshold dose of 100 ng per gram of body weight had an acute
and significant effect on daily food intake, even before body weight decreases (statistics
imbedded in text). (c) ob/ob;Chr2þ mice, but not ob/ob;Chr2 mice, were sensitive to the
rewarding effect of optogenetic activation of DA neurons during a regimen of leptin treatment of
100 ng per gram of body weight. ob/ob;Chr2þ , but not ob/ob;Chr2 mice, prefer to lick the
sipper coupled to laser stimulation of DA neurons. (d) Control ob/ob;Chr2 mice preferred
sucrose to sucralose coupled to laser stimulation of DA neurons, but ob/ob;Chr2þ mice
preferred the reverse (statistics imbedded in text). Bars are mean7SEM, *po0.031,
****po0.00000023.3.4. Threshold leptin treatment in ob/ob mice decreases the reward
value of sucrose before weight loss
After implanting new osmotic pumps dispensing 100 ng/h of leptin (the
threshold dose), animals consumed signiﬁcantly less food relative to
untreated ob mice or mice receiving the subthreshold dose: 33.6%76 MOLECULAR METABOLISM 3 (2014) 73–80 & 2013 The Audecrease in the ob/ob;Chr2 mice and a 31.2% reduction in the ob/ob;
Chr2þ at 48 h post-treatment was noted (Figure 4a, p40.4, two-
sample t-test). There was no difference in body weight after 48 h in
these two groups. (p40.3, two-sample t-test) (Figure 4b).thors. Published by Elsevier GmbH. www.molecularmetabolism.comOpen access under CC BY-NC-ND license.
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Figure 5: Leptin deficiency upregulates the reward value of sucrose. (a and b) Leptin
deficiency by treatment withdrawal rapidly reverses changes in daily food intake (statisticsBehavioral tests were performed 48 h after treatment with the higher
leptin dose. As in Section 3.3 we ﬁrst tested whether leptin treatment of
100 ng per gram of body weight altered the rewarding effect of
optogenetic activation of DA neurons per se (Figure 4c). We found that
similar to control mice, ob/ob;Chr2þ mice (n¼8) still preferred water
coupled to optogenetic activation of DA neurons to water alone
(Figure 4c). ob/ob;Chr2þ mice had 7774% preference for the sipper
that was coupled to laser activation compared to a of 50711%
preference ratio of ob/ob;Chr2 mice (n¼8, *po0.031, two-sample
t-test).
We next tested the effect of this leptin dose on the reward value of
sucrose. When given a choice between sucrose versus sucralose
coupled to laser activation, control ob/ob;Chr2 mice preferred the
port with the sucrose with a preference ratio for sucrose of 7874%
(n¼8) (Figure 4d). In contrast, for ob/ob;Chr2þ mice, threshold leptin
treatment (100 ng/h) resulted in a reversal of this preference with a
preference ratio for sucrose of 2074% (n¼8, signiﬁcantly different
from the preference ratio of ob/ob;Chr2 mice, ******po0.00000023,
two-sample t-test) (Figure 4d). Thus, a dose of leptin capable of
reducing food intake profoundly also suppressed the reward value of
sucrose, even before weight loss was achieved (Figure 4).
3.5. Leptin deﬁciency increases the reward value of sucrose
At the conclusion of 48 h of threshold leptin treatment, the pumps
delivering 100 ng/h of leptin were removed and replaced with new
osmotic pumps ﬁlled with vehicle (Figure 5). At 48 h post-leptin
withdrawal food intake of ob/ob;Chr2 and ob/ob;Chr2þ mice, was
signiﬁcantly increased compared to the food intake at the threshold dose
(ob/ob;Chr2 :po0.00013 and ob/ob;Chr2þ :po 0.023, two-sample
t-test) (Figures 4 and 5a). Body weight increased by 5.2% in ob/ob;
Chr2 mice and by 4.9% in ob/ob;Chr2þ , but this increase was not
statistically signiﬁcant. (ob/ob;Chr2 :p40.33 and ob/ob;Chr2þ :
p40.35, two-sample t-test) (Figures 4 and 5b).
Forty-eight hours after removal of the leptin pumps, ob/ob;Chr2þ mice
(n¼8) preferred water coupled to laser activation of DA neurons with a
7975% preference for the sipper that was coupled to laser activation
versus the sipper containing water alone (Figure 5). This preference ratio
was signiﬁcantly different from the preference ratio of ob/ob;Chr2
mice (n¼8), which scored a 4577% preference for the laser side
(**po0.0012, two-sample t-test) (Figure 5c). Finally, we measured the
reward value of sucrose in leptin deﬁcient mice, (post-leptin withdrawal)
and found that both ob/ob;Chr2 and ob/ob;Chr2þ animals preferred
sucrose to sucralose coupled to laser activation with preference ratios,
of 8672% (n¼8) and 8874% (n¼8) (p40.39 two-sample t-test)
respectively (Figure 5d). This preference ratio is also similar to that of
ob/ob;Chr2þ animals treated with a subthreshold dose of leptin (p40.34
two-sample t-test, compared with ob/ob;Chr2þ in Figure 3d). These data
indicate that leptin deﬁciency strongly increases the reward value of sucrose
(Figure 5d).imbedded in text). (c) ob/ob;Chr2þ mice, but not ob/ob;Chr2 mice, were sensitive to the
rewarding effect of optogenetic activation of DA neurons after leptin treatment withdrawal.
ob/ob;Chr2þ , but not ob/ob;Chr2 mice, preferred to lick the sipper coupled to laser
stimulation of DA neurons. (d) Both ob/ob;Chr2þ and control ob/ob;Chr2 mice preferred
sucrose to sucralose coupled to laser stimulation of DA neurons 48 h after leptin treatment
withdrawal (statistics imbedded in text). Bars are mean7SEM, **po0.0012.4. DISCUSSION
Animals and humans generally prefer sweeteners with nutrient value
compared to non-nutritive sweeteners such as sucralose [2,9–13]. This
preference is a result of the post-ingestive rewarding effect of sucrose
[2]. The post-ingestive effect of sucrose was ﬁrst described by showing
that inert liquids that are paired to glucose administration either in the GI
tract or in plasma, are greatly preferred to liquids that are not paired
with nutrient [14,15]. In addition, sweet blind TRPM5 knockout mice canMOLECULAR METABOLISM 3 (2014) 73–80 & 2013 The Authors. Published by Elsevier GmbH. Open astill sense the nutrient value of sucrose [16,17]. These studies have
indicated that the nutrient value of sucrose is sensed and that, in turn,
establishes preference for nutritive sweeteners [2,14–18]. The preference
for sucrose relative to artiﬁcial sweeteners is associated with striatal
dopamine release, resulting in a rewarding effect of sugar [2,14–18]. The77www.molecularmetabolism.comccess under CC BY-NC-ND license.
Brief Communicationpost-ingestive effect plays a major role in driving nutrient choice rather
than sweet taste [14–18]. The combination of sweet taste and an increase
of dopamine accounts for the preference for natural versus artiﬁcial
sweeteners [2].
In humans, food hedonics (“liking”) is measured with a subjective rating
scale, but this scale cannot be used in studies of animals that cannot
self-report. Current assays of “liking” in animals use subjective
measures of orofacial expressions, similar to those used in human
infants [19]. Rodent assays based on orofacial expressions have not
been reported to distinguish between artiﬁcial and natural sweeteners.
However, both humans and mice prefer natural to artiﬁcial sweeteners
[2,10–14]. In addition, assays of orofacial expression in rodents predict
that dopamine does not play a role in the hedonic value of sucrose [19]
although several reports are consistent with a central role of dopamine:
sucrose intake rapidly increases blood glucose, which leads to
dopaminergic activation independent of taste perception, eliciting the
post-ingestive rewarding effect of sucrose [2,15–19]. Artiﬁcial sweet-
eners, such as sucralose, do not raise blood glucose and lack this post-
ingestive rewarding effect, which explains the innate preference for
sucrose relative to sucralose [2,15–19]. As an alternative assay of food
hedonics, we recently developed a two-bottle forced choice assay
measuring preference for sucrose versus a reference stimulus in which
ingestion of sucralose induces optogenetic stimulation of DA neurons
[2]. In this assay, changes in preference relative to this reference
stimulus reﬂect changes in the reward value of the nutrient in the
second port, which in these studies is sucrose [2]. A choice behavior
denotes the relative value of each option, as this optogenetic assay
builds on neuroeconomic analyses of behavior, which can be general-
ized from humans to any species capable of making behavioral
decisions [20–23]. In addition, choice behaviors can be automatically
quantiﬁed with digital sensors, unlike subjective evaluation of orofacial
expressions [2,20].
Using this optogenetic assay we have previously shown that the natural
preference for sucrose versus sucralose could be inverted if ingestion of
sucralose is supplemented by a proxy post-ingestive effect, in the form of
optogenetic activation of DA neurons [2]. The reward value of sucrose was
increased by fasting, and was decreased by leptin infusion [2]. However,
these studies carried out in non-obese mice with intact leptin genes, and
hence the effect of body weight and the hormonal action of endogenous
leptin's on behavior could not be dissociated.
Leptin-deﬁcient patients express high ratings for how much they “like”
food prior to leptin treatment with a striking decrease in the “liking” score
after leptin treatment. Hormone replacement of leptin deﬁcient patients
normalizes these ratings even before weight loss is achieved [1].
In this report we extend previous ﬁndings by showing that the reward
value of sucrose in leptin-deﬁcient ob mice is higher, and that leptin
treatment normalizes the reward value of sucrose even before
signiﬁcant weight loss is achieved. These studies also allowed us to
analyze the dose response relationship between leptin and the reward
value of sucrose. This controlled dosage could not have been achieved
in wild-type mice, which still have signiﬁcant circulating levels of leptin
even after weight loss.
As we implanted optical ﬁbers that are required for the optogenetic
reference stimulus, we found that leptin-deﬁcient mice were highly
susceptible to complications during and after the surgery. Similar to this
observation, low leptin levels have also been associated with compli-
cated postoperative course of cardiac surgery in humans [24]. Treat-
ment with the low dose of leptin that signiﬁcantly reduced surgical
complications had no effect on body weight, food intake, and did not
change the reward value of sucrose, even after 28 days of treatment.78 MOLECULAR METABOLISM 3 (2014) 73–80 & 2013 The AuInfusion of a higher dose of leptin, which increased plasma leptin levels
to about 4 ng/mL, decreased food intake before signiﬁcant weight loss
is achieved. To test the effect of leptin deﬁciency, the infusion pumps
were removed. After 48 h serum leptin levels had dropped to the
background levels as observed in untreated ob/ob mice. Food intake and
the reward value of sucrose were strongly increased to levels that were
observed during treatment with the low dose of leptin. Thus we show
that leptin deﬁciency augments the reward value of sucrose, even before
weight loss is achieved. We ﬁnd that the effect of leptin on reward is
dose dependent and correlated with its effects on food intake. In
humans, changes in “liking” are correlated with changes in brain activity
in reward-related regions such as the striatum [1]. This effect of leptin is
in contrast to caloric restriction (dieting), which increases the perceived
reward of food – “liking food” [1,2,25,26]. In humans, leptin deﬁciency
is linked to food hedonics, but the same has been difﬁcult to show in
rodents. Others have analyzed the effects of leptin using operant
conditioning assays such as progressive ratio (PR) schedules of
reinforcement, or conditioned place preference (CPP) [27–29]. In a PR
task, the subject is required to trigger an increasing number of operant
responses for each successive reward. The number of responses
triggered to obtain the last reward (“break point”) serves as an index
of the willingness to work for food [27–29]. This operant procedure can
be used in humans and animals [14,15,20]. Animals will work (press
lever) because they are hungry. Animals will not work if not hungry. It is
well known that leptin curbs hunger ratings, being known as an
anorexigenic hormone. Hence lower hunger, or lower motivation to
work, might be the reason why leptin decreased output in a lever-press
operand task. Operant tasks are contingent upon a subject's motiva-
tional state to work, which limits its utility for assessing the pleasurable
value of food. In fact, these assays cannot dissociate hunger, reward,
and motivation work, hence preventing any conclusion about “food
hedonics”. Because operant assays such as PR od CPP are one-way
forced tasks (providing animals with only one choice – to work if
hungry), reward and hunger are obscured by the motivation to work. In
contrast, our assay provides two symmetric choices for ingesting a
solution such that the amount of “work” required for licking either spout
is the same. Because of this symmetry, we can exclude any confounds
generated by “motivation to work”.
In summary, using a novel optogenetic assay we show that leptin
deﬁciency augments the reward value of sucrose and that leptin
treatment of ob mice reduces the reward value of sucrose, even before
weight loss is achieved. These results phenocopy in a mouse model of
obesity the clinical effects of leptin on a complex behavior of leptin-
deﬁcient patients, further validating our novel optogenetic assay to
experimentally probe the reward value of food. The cellular and neural
mechanisms by which leptin regulates the reward value of sucrose
remain to be elucidated. Since leptin's primary site of action is the brain,
further studies will be necessary to establish whether leptin acts on a
heretofore unidentiﬁed nutrient sensor in the brain that conveys the
reward value of sucrose [30–33]. As our assay can be easily generalized
to ingestible fats, future studies will assay whether fat and sugar utilize
the same circuitry to convey reward.ACKNOWLEDGMENTS
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Figure A1: Food intake and body weight throughout leptin treatment: (a) percent change of food intake relative to the previous measurements, starting at pre-treatment on day 0; (b) percent
change of body weight on the previous measurements, starting at pre-treatment on day 0.CONFLICT OF INTEREST
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